Wells Fargo & Company Atea Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 35,526 shares of AVIR stock, worth $115,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,526

Previous 34,354 3.41%

Holding current value

$115,459

Previous $113,000 5.31%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.17 - $4.02 $3,715 - $4,711	1,172 Added 3.41%	35,526 $119,000
Q2 2024 Aug 13, 2024	BUY	$3.31 - $4.04 $22,557 - $27,532	6,815 Added 24.75%	34,354 $113,000
Q1 2024 May 10, 2024	BUY	$3.09 - $4.56 $10,737 - $15,845	3,475 Added 14.44%	27,539 $111,000
Q4 2023 Feb 09, 2024	BUY	$2.8 - $3.35 $12,913 - $15,450	4,612 Added 23.71%	24,064 $73,000
Q3 2023 Nov 13, 2023	SELL	$3.0 - $3.79 $30,747 - $38,843	-10,249 Reduced 34.51%	19,452 $58,000
Q2 2023 Aug 15, 2023	BUY	$3.21 - $5.06 $50,194 - $79,123	15,637 Added 111.18%	29,701 $111,000
Q1 2023 May 12, 2023	BUY	$3.0 - $4.97 $40,692 - $67,413	13,564 Added 2712.8%	14,064 $47,000
Q4 2022 Feb 13, 2023	SELL	$4.35 - $6.17 $848 - $1,203	-195 Reduced 28.06%	500 $2,000
Q3 2022 Nov 14, 2022	SELL	$5.49 - $8.79 $3,414 - $5,467	-622 Reduced 47.23%	695 $4,000
Q2 2022 Aug 12, 2022	SELL	$5.33 - $8.18 $154,655 - $237,350	-29,016 Reduced 95.66%	1,317 $10,000
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $117,865 - $196,941	-21,430 Reduced 41.4%	30,333 $219,000
Q4 2021 Feb 14, 2022	SELL	$7.67 - $44.59 $1.76 Million - $10.3 Million	-229,956 Reduced 81.63%	51,763 $463,000
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $6 Million - $9.87 Million	281,441 Added 101237.77%	281,719 $9.88 Million
Q2 2021 Aug 16, 2021	SELL	$19.22 - $59.08 $82,415 - $253,335	-4,288 Reduced 93.91%	278 $6,000
Q1 2021 May 13, 2021	SELL	$41.42 - $88.44 $124,094 - $264,966	-2,996 Reduced 39.62%	4,566 $282,000
Q4 2020 Feb 09, 2021	BUY	$26.36 - $41.78 $199,334 - $315,940	7,562 New	7,562 $316,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $271M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Atea Pharmaceuticals, Inc. Transaction History